Russia Launches New Drugs for Emergency Bleeding Control

Two new medications for emergency bleeding control have appeared in Russia — lyophilized cryoprecipitate and lyophilized spun cryoprecipitate.

Consensus

Two new drugs for emergency bleeding control have been introduced in Russia.
The drugs are cryoprecipitate lyophilized (KRYO-L) and pulsed cryoprecipitate lyophilized (KROYO-PL).
They contain four times more clotting-related proteins than an equivalent volume of lyophilized plasma.
The drugs are in a dried form produced using sublimation drying.
They can be stored at temperatures between +5°C and +20°C.
The shelf life of the drugs is extended compared to analogs.
The drugs can be used by emergency medical teams and military medics in the field without waiting for frozen blood components.
The drugs help stop bleeding within minutes by replenishing key clotting proteins.
The introduction of the drugs was announced by Veronika Skvortsova, head of the Federal Medical-Biological Agency.

On September 15, a new drug for treating pulmonary arterial hypertension was registered in Russia, marking the first Russian generic in tablet form. — vm
In late July, the Russian Minister of Health Mikhail Murashko announced new radiation therapy technologies that protect healthy tissue during treatment. — vedomosti